Ck7+ ck20+ tumors

Por um escritor misterioso
Last updated 24 dezembro 2024
Ck7+ ck20+ tumors
Ck7+ ck20+ tumors
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - ScienceDirect
Ck7+ ck20+ tumors
PDF] CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Ck7+ ck20+ tumors
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers - ScienceDirect
Ck7+ ck20+ tumors
Cytokeratin 7 (MSVA-607R) - MS Validated Antibodies
Ck7+ ck20+ tumors
Ck7+ ck20+ tumors
Pathology Outlines - Cytokeratin 7 (CK7, K7)
Ck7+ ck20+ tumors
Table 1 from Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Ck7+ ck20+ tumors
Utility of five commonly used immunohistochemical markers TTF‐1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine
Ck7+ ck20+ tumors
Cytokeratin 7 (MSVA-607R) - MS Validated Antibodies
Ck7+ ck20+ tumors
CK7 CK20 Carcinoma Antibody Duo (ARG30318) - arigo Biolaboratories
Ck7+ ck20+ tumors
Identical cytokeratin expression pattern CK7+/CK20− in esophageal and cardiac cancer: etiopathological and clinical implications
Ck7+ ck20+ tumors
Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors
Ck7+ ck20+ tumors
Comparison of coordinate CK7/CDX2 and CK7/CK20 profiles in primary
Ck7+ ck20+ tumors
Cytokeratin 7 (MSVA-607R) - MS Validated Antibodies

© 2014-2024 startwindsor.com. All rights reserved.